Increased Risk Of Death From Lung Cancer With Hormone Replacement Therapy

An article published Online First and in a future edition of The Lancet reports that hormone replacement therapy (HRT) using oestrogen and progestin increases the risk of death from lung cancer. This finding should be included into risk-benefit consideration for women considering HRT. It is especially essential for women at high risk of lung cancer.